Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acasti Pharma Inc. (ACST) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acasti Pharma Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1444192.
Total stock buying since 2023: $1,249,933.
Total stock sales since 2023: $0.
Total stock option exercises since 2023: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 676,371 | $1,249,933 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 676,371 | $1,249,933 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-25 | Kavuru Vimal (Director) | Buy | 676,371 | 1.85 | 1,249,933 |
Insider trading activities including stock purchases, stock sales, and option exercises of ACST listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acasti Pharma Inc. (symbol ACST, CIK number 1444192) see the Securities and Exchange Commission (SEC) website.